Guided Therapeutics, Inc. (GTHP)

Market Cap	9.75M
Revenue (ttm)	1,000.00
Net Income (ttm)	-2.61M
Shares Out	77.97M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,271
Average Volume	9,911
Open	0.1095
Previous Close	0.0900
Day's Range	0.1050 - 0.1400
52-Week Range	0.0640 - 0.2300
Beta	0.20
RSI	63.83
Earnings Date	May 14, 2025

About Guided Therapeutics

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected and fluorescent light. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was incorpo...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1992
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: GTHP

Financial Performance

In 2024, Guided Therapeutics's revenue was $7,000, a decrease of -92.86% compared to the previous year's $98,000. Losses were -$2.59 million, -31.07% less than in 2023.